Melatonin interferes in the desmoplastic reaction in breast cancer by regulating cytokine production

Journal of Pineal Research

Volumn 52, Issue 3, 2012, Pages 282-290

  Alvarez García, Virginia ^a   González, Alicia ^a   Alonso González, Carolina ^a   Martínez Campa, Carlos ^a   Cos, Samuel ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

3T3 L1 cells; aromatase; breast cancer; interleukins; melatonin; pineal gland; tumor necrosis factor

Indexed keywords

AROMATASE; INTERLEUKIN 11; INTERLEUKIN 6; MELATONIN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ARTICLE; BREAST CANCER; CANCER CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOKINE PRODUCTION; FIBROBLAST; HUMAN; HUMAN CELL;

3T3-L1 CELLS; ANIMALS; AROMATASE; BASE SEQUENCE; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; COCULTURE TECHNIQUES; CYTOKINES; DNA PRIMERS; FEMALE; HUMANS; MELATONIN; MICE;

EID: 84858751360     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2011.00940.x     Document Type: Article

References (64)

1. Russo IH, Russo J,. Role of hormones in mammary cancer initiation and progression. J Mammary Gland Biol Neoplasia 1998; 3: 49-61. (Pubitemid 128513219)
2. Russo J, Russo IH,. The role of estrogen in the initiation of breast cancer. J Steroid Biochem Mol Biol 2006; 102: 89-96. (Pubitemid 44750629)
3. Orlando L, Schiavone P, Fedele P, et al., Molecularly targeted endocrine therapies for breast cancer. Cancer Treat Rev 2010; 36S (3): S67-S71.
4. Landeghem AA, Poortman J, Nabuurs M, et al., Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue. Cancer Res 1985; 45: 2900-2906. (Pubitemid 15232767)
5. Yue W, Wang JP, Hamilton CJ, et al., In situ aromatization enhances breast tumor estradiol levels and cellular proliferation. Cancer Res 1998; 58: 927-932. (Pubitemid 28182460)
6. Simpson ER,. Role of aromatase in sex steroid action. J Mol Endocrinol 2000; 25: 149-156.
7. Cos S, Sánchez-Barceló EJ,. Melatonin and mammary pathological growth. Front Neuroendocrinol 2000; 21: 133-170. (Pubitemid 30228502)
8. Cos S, Sánchez-Barceló EJ,. Melatonin, experimental basis for a possible application in breast cancer prevention and treatment. Histol Histopathol 2000; 15: 637.
9. Cos S, González A, Martínez-Campa C, et al., Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions. Cancer Detect Prev 2006; 30: 118-128. (Pubitemid 43766230)
10. Blask DE, Sauer LA, Dauchy RT,. Melatonin as a chronobiotic/anticancer agent: cellular, biochemical and molecular mechanisms of action and their implications for circadian-based cancer therapy. Curr Topics Med Chem 2002; 2: 113-132.
11. Hill SM, Blask DE,. Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res 1988; 48: 6121-6126. (Pubitemid 18266811)
12. Mediavilla MD, Sánchez-Barceló EJ, Tan DX, et al., Basic mechanisms involved in the anti-cancer effects of melatonin. Curr Med Chem 2010; 17: 4462-4481.
13. Jung-Hynes B, Huang W, Reiter RJ, et al., Melatonin resynchronizes dysregulated circadian rhythm circuitry in human prostate cancer cells. J Pineal Res 2010; 49: 60-68.
14. Leja-Szpak A, Jaworek J, Pierzchalski P, et al., Melatonin induces pro-apoptotic signaling pathway in human pancreatic carcinoma cells (PANC-1). J Pineal Res 2010; 99: 248-255.
15. Casado-Zapico S, Martín V, García-Santos G, et al., Regulation of the expression of death receptors and their ligands by melatonin in haematological cancer cell lines and in leukaemia cells from patients. J Pineal Res 2011; 50: 345-355.
16. Sánchez-Barceló EJ, Cos S, Fernández R, et al., Melatonin and mammary cancer: a short review. Endocr Relat Cancer 2003; 10: 153-159. (Pubitemid 36758644)
17. Sánchez-Barceló EJ, Cos S, Mediavilla MD, et al., Melatonin-estrogen interactions in breast cancer. J Pineal Res 2005; 38: 217-222. (Pubitemid 41475432)
18. Cos S, González A, Martínez-Campa C, et al., Melatonin as a selective estrogen enzyme modulator. Curr Cancer Drug Tar 2008; 8: 691-702.
19. González A, Cos S, Martínez-Campa C, et al., Selective estrogen enzyme modulator (SEEM) actions of melatonin in human breast cancer cells. J Pineal Res 2008; 45: 86-92. (Pubitemid 351986266)
20. Zhou D, Wang J, Chen E, et al., Aromatase gene is amplified in MCF-7 human breast cancer cells. J Steroid Biochem Mol Biol 1993; 46: 147-153. (Pubitemid 23251672)
21. Sonne-Hansen K, Lykkesfeldt AE,. Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line. J Steroid Biochem Mol Biol 2005; 93: 25-34. (Pubitemid 40312730)
22. Ram PT, Kiefer T, Silverman M, et al., Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factors. Mol Cell Endocrinol 1998; 141: 53-64. (Pubitemid 28393379)
23. Ram PT, Dai J, Yuan L, et al., Involvement of the MT-1 melatonin receptor in human breast cancer. Cancer Lett 2002; 179: 141-150. (Pubitemid 34215105)
24. Cos S, Martínez-Campa C, Mediavilla MD, et al., Melatonin modulates aromatase activity in MCF-7 human breast cancer cells. J Pineal Res 2005; 38: 136-142. (Pubitemid 40293239)
25. Martínez-Campa C, González A, Mediavilla MD, et al., Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cáncer cells. Br J Cancer 2009; 101: 1613-1619.
26. Cos S, González A, Güezmes A, et al., Melatonin inhibits the growth of DMBA-induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activity. Int J Cancer 2006; 118: 274-278. (Pubitemid 41779064)
27. González A, Alvarez-García V, Martínez-Campa C, et al., Melatonin promotes differentiation of 3T3-L1 fibroblasts. J Pineal Res 2011; 52: 12-20.
28. Bulun SE, Lin Z, Imir G, et al., Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol Rev 2005; 57: 359-383. (Pubitemid 41196955)
29. Meng LI, Zhou J, Sasano H, et al., Tumor necrosis factor α and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein α and peroxisome proliferator-activated receptor γ: mechanism of desmoplastic reaction. Cancer Res 2001; 61: 2250-2255. (Pubitemid 32692055)
30. Ramírez-Zacarias JL, Castro-Muñozledo F, Kuri-Harcuch W,. Quantitation of adipose conversión and triglycerides by staining intracytoplasmic lipids with Oil red O. Histochemistry 1992; 97: 493-497.
31. Mosmann T,. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63. (Pubitemid 14203433)
32. Ackerman GE, Smith ME, Mendelson CR, et al., Aromatization of androstenedione by human adipose tissue stromal cells in monolayer culture. J Clin Endocrinol Metab 1981; 53: 412-417. (Pubitemid 13250304)
33. Hollingshead BD, Beischlag TV, Dinatale BC, et al., Inflammatory signaling and aryl hydrocarbon receptor mediate synergistic induction of interleukin 6 in MCF-7 cells. Cancer Res 2008; 68: 3609-3617.
34. Pasqualini JR,. The selective estrogen enzyme modulators in breast cancer: a review. Biochim Biophys Acta 2004; 1654: 123-143. (Pubitemid 38681205)
35. Pasqualini JR, Chetrite GS,. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer. J Steroid Biochem Mol Biol 2005; 93: 221-236. (Pubitemid 40602495)
36. Suzuki T, Miki Y, Nakamura Y, et al., Sex steroid-producing enzymes in human breast cancer. Endocr Relat Cancer 2005; 12: 701-720. (Pubitemid 41815772)
37. Bulun SE, Chen D, Lu M, et al., Aromatase excess in cancers of breast, endometrium and ovary. J Steroid Biochem Mol Biol 2007; 106: 81-96. (Pubitemid 47362640)
38. Purohit A, Newman SP, Reed MJ,. The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer. Breast Cancer Res 2002; 4: 65-69. (Pubitemid 34248122)
39. Guerrero J, Tobar N, Caceres M, et al., Soluble factors derived from tumor mammary cell lines induce a stromal mammary adipose reversion in human and mice adipose cells. Possible role of TGF-β1 and TNF-α. Breast Cancer Res Treat 2010; 119: 497-508.
40. Molis TM, Spriggs LI, Hill SM,. Modulation of estrogen receptor mRNA expression by melatonin in MCF-7 human breast cancer cells. Mol Endocrinol 1994; 8: 1681-1690.
41. Hill SM, Spriggs LL, Simon MA, et al., The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system. Cancer Lett 1992; 64: 249-256.
42. Delrio B, García-Pedrero JM, Martínez-Campa C, et al., Melatonin: an endogenous specific inhibitor of estrogen receptor α via calmodulin. J Biol Chem 2004; 279: 38294-38302. (Pubitemid 39295977)
43. Ntambi JM, Kim YC,. Adipocyte differentiation and gene expression. J Nutr 2000; 130: 3122S-3126S. (Pubitemid 32005353)
44. Yamada K, Harada N,. Expression of estrogen synthetase (P-450 aromatase) during adipose differentiation of 3T3-L1 cells. Biochem Biophys Res Commun 1990; 169: 531-536. (Pubitemid 20216140)
45. Cos S, Verduga R, Fernández-Viadero C, et al., Effects of melatonin on the proliferation and differentiation of human neuroblastoma cells in culture. Neurosci Lett 1996; 216: 113-116. (Pubitemid 26327037)
46. Crespo D, Fernández-Viadero C, Verduga R, et al., Interaction between melatonin and estradiol on morphological and morphometric features of MCF-7 human breast cancer cells. J Pineal Res 1994; 16: 215-222.
47. Cos S, Fernández R,. Melatonin effects on intercellular junctional communication in MCF-7 human breast cancer cells. J Pineal Res 2000; 29: 166-171.
48. Sainz RM, Mayo JC, Tan DX, et al., Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism. Prostate 2005; 63: 29-43. (Pubitemid 40365388)
49. Radio NM, Doctor JS, Witt-Enderby PA,. Melatonin enhances alkaline phosphatase activity in differentiating human adult mesenchymal stem cells grown in osteogenic medium via MT2 melatonin receptors and the MEK/ERK (1/2) signaling cascade. J Pineal Res 2006; 42: 332-342.
50. Zhang L, Su P, Xu C, et al., Melatonin inhibits adipogenesis and enhances osteogenesis of human mesenchymal stem cells by suppressing PPARγ expression and enhancing Runx2 expression. J Pineal Res 2010; 49: 364-372.
51. Moriya Y, Horie N, Mitome M, et al., Melatonin influences the proliferative and differentiative activity of neural stem cells. J Pineal Res 2007; 42: 411-418. (Pubitemid 46581666)
52. Sanchez-Hidalgo M, Lu Z, Tan DX, et al., Melatonin inhibits fatty acid-induced triglyceride accumulation in ROS17/2.8 cells: implications for osteoblast differentiation and osteoporosis. Am J Physiol Regul Integr Comp Physiol 2007; 292: R2208-R2215. (Pubitemid 47080681)
53. Lane MD, Tang QQ,. From multipotent stem cell to adipocyte. Birth Defects Res A 2005; 73: 476-477. (Pubitemid 41045292)
54. Pasqualini JR, Chetrite GS,. Estradiol as an anti-aromatase agent in human breast cancer cells. J Steroid Biochem Mol Biol 2006; 98: 12-17. (Pubitemid 43113239)
55. Yue W, Berstein LM, Wang JP, et al., The potential role of estrogen in aromatase regulation in the breast. J Steroid Biochem Mol Biol 2001; 79: 157-164. (Pubitemid 34158790)
56. Torti FM, Torti SV, Larrick JW, et al., Modulation of adipocyte differentiation by tumor necrosis factor and transforming growth factor β. J Cell Biol 1989; 108: 1105-1113. (Pubitemid 19083754)
57. Keller DC, Du XX, Srour EF, et al., Interleukin-11 inhibits adipogenesis and stimulates myelopoiesis in human long-term marrow cultures. Blood 1993; 82: 1428-1435. (Pubitemid 23263958)
58. Rubin GL, Zhao Y, Kalus AM, et al., Peroxisome proliferator-activated receptor γ ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy. Cancer Res 2000; 60: 1604-1608. (Pubitemid 30183431)
59. Sullivan NJ, Sasser AK, Axel AE, et al., Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene 2009; 28: 2940-2947.
60. Cos S, Fernández R, Güezmes A, et al., Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Cancer Res 1998; 58: 4383-4390. (Pubitemid 28450041)
61. Tocharus J, Khontun C, Chongthammakun S, et al., Melatonin attenuates methamphetamine-induced overexpression of pro-inflammatory cytokines in microglial cell lines. J Pineal Res 2010; 48: 347-352.
62. Choi EY, Jin JY, Lee JY, et al., Melatonin inhibits prevotella intermedia lipopolysaccharide-induced production of nitric oxide and interleukin-6 in murine macrophages by suppressing NF-B and STAT1 activity. J Pineal Res 2011; 50: 197-206.
63. Tai SH, Hung YC, Lee EJ, et al., Melatonin protects against transient focal cerebral ischemia in both reproductively active and estrogen-deficient female rats: the impact of circulating estrogen on its hermetic dose-response. J Pineal Res 2011; 50: 292-303.
64. Fraschini F, Demartini G, Esposti D, et al., Melatonin involvement in immunity and cancer. Biol Signals Recept 1998; 7: 61-72. (Pubitemid 28266313)